Gabriel Ocana Santero

Gabriel Ocana Santero is a neuroscientist and researcher developing gene therapies for neurological conditions based in Oxford, United Kingdom. He completed his doctoral studies in pharmacology at Oxford University, where his research examined the effects of SSRI antidepressants on early neural activity under the supervision of Trevor Sharp and Simon Butt. Prior to his doctoral work, he earned a biochemistry degree from the Autonomous University of Madrid in 2020 and secured research funding through the Marie Skłodowska-Curie Action. His academic career includes computational research utilizing neuroAI models at University College London, alongside international research stays at the Medical University of Vienna, the Karolinska Institute, and Boston University. Ocana Santero currently focuses on bridging biological research and computational neuroscience to better understand brain function and advance targeted gene therapies for complex neurological disorders.